Deal round up 27/09/02

Softbank, Sofinnova back Cril Telecom first round; Invision leads Trados first round; CDC exits Costa Rican investment; Siparex backs Orsco acquisition

Softbank, Sofinnova back Cril Telecom first round

Softbank Europe Ventures, a $600m venture capital fund focusing on early-stage technology companies in Europe and Israel, has led a E11m first round of investment for Cril Telecom, a provider of advanced network planning based in Paris.

Softbank was joined in the investment round by Sofinnova Partners. The new capital will be used by Cril Telecom Software to finance the firm’s growth into new markets as well as providing funds for further development of the company’s software.

Invision leads Trados first round

Swiss private equity firm Invision has invested $2m in Trados Corporation, a US developer of language technology solutions. The unsolicited investment will introduce Trados' translation solutions to Invision's portfolio and related companies. Invision will also assist TRADOS in boosting its presence in the Swiss and German markets.

Trados provides translation services for a number of major global businesses including Microsoft, Hewlett Packard, SAP, Volkswagen and NATO. Invision invests primarily in technology investments. Its most recent deal was an investment in a E14m round for German telecom service provider mcn tele.com.

CDC exits Costa Rican investment

Emerging markets investment firm CDC Capital Partners has completed the sale of the ACI group of companies in Costa Rica. ACI produces and distributes whole tilapia and tilapia fillets, one of the top ten seafood products in the US.

CDC made its first investment in ACI in 1989. Since then the firm has developed the business’ farming and production facilities. The business is being acquired by an investor group led by company management. The financial details of the transaction have not been disclosed.

Siparex backs Orsco acquisition

French investment firm Siparex Croissance has provided E2m as part of a E6.5m financing round for Orsco, a French pharmaceuticals business based in Lyon. Orsco has raised the capital to finance the acquisition of Medicrea, a manufacturer of medical equipment.

Other investors in the round include French investment firm Robertsau Investissement and existing shareholders. Siparex made its investment through FCPR Rhône-Alpes PME. In 2001, Orsco and Medicrea posted net income of E820,000 on consolidated sales of E5.1m.